Dana H. Shin

Array ( [id] => 19089702 [patent_doc_number] => 11951121 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-09 [patent_title] => Compositions and methods for treating Huntington's disease [patent_app_type] => utility [patent_app_number] => 16/302140 [patent_app_country] => US [patent_app_date] => 2017-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77616 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11943550 [patent_doc_number] => 20170247701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPI' [patent_app_type] => utility [patent_app_number] => 15/594600 [patent_app_country] => US [patent_app_date] => 2017-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23330 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15594600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11943549 [patent_doc_number] => 20170247700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPI' [patent_app_type] => utility [patent_app_number] => 15/594599 [patent_app_country] => US [patent_app_date] => 2017-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23332 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15594599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16506459 [patent_doc_number] => 20200385715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-10 [patent_title] => COMPOSITIONS AND METHODS FOR ALTERING BACTERIA FITNESS [patent_app_type] => utility [patent_app_number] => 16/300372 [patent_app_country] => US [patent_app_date] => 2017-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25841 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14687521 [patent_doc_number] => 20190242875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => Expression Inhibitor of Inflammation Promoting Factor, Screening Method for Active Ingredient Thereof, Expression Cassette Useful for Said Method, Diagnostic Agent and Diagnosis Method [patent_app_type] => utility [patent_app_number] => 16/300442 [patent_app_country] => US [patent_app_date] => 2017-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15268121 [patent_doc_number] => 20190382794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => MITOCHONDRIAL DELIVERY OF RECOMBINANT NUCLEIC ACIDS [patent_app_type] => utility [patent_app_number] => 16/099151 [patent_app_country] => US [patent_app_date] => 2017-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21274 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16238603 [patent_doc_number] => 20200255837 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-08-13 [patent_title] => SPHERICAL NUCLEIC ACID TLR9 AGONISTS [patent_app_type] => utility [patent_app_number] => 16/099404 [patent_app_country] => US [patent_app_date] => 2017-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11167 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -58 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16238603 [patent_doc_number] => 20200255837 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-08-13 [patent_title] => SPHERICAL NUCLEIC ACID TLR9 AGONISTS [patent_app_type] => utility [patent_app_number] => 16/099404 [patent_app_country] => US [patent_app_date] => 2017-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11167 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -58 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11994292 [patent_doc_number] => 20170298447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'MICRORNAS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/586747 [patent_app_country] => US [patent_app_date] => 2017-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14677 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12172254 [patent_doc_number] => 09890382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-13 [patent_title] => 'Nucleic acid compositions related to MIR-138-1-3P and uses thereof' [patent_app_type] => utility [patent_app_number] => 15/586783 [patent_app_country] => US [patent_app_date] => 2017-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 13 [patent_no_of_words] => 28751 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14278071 [patent_doc_number] => 20190136320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => MICRORNA BIOMARKERS IN BLOOD FOR DIAGNOSIS OF ALZHEIMER'S DISEASE [patent_app_type] => utility [patent_app_number] => 16/096219 [patent_app_country] => US [patent_app_date] => 2017-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16013 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11852018 [patent_doc_number] => 20170226510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'MICRORNAS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/731118 [patent_app_country] => US [patent_app_date] => 2017-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15268 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15731118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15114619 [patent_doc_number] => 20190343942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-14 [patent_title] => RNA ENCODING A TUMOR ANTIGEN [patent_app_type] => utility [patent_app_number] => 16/094995 [patent_app_country] => US [patent_app_date] => 2017-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50504 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14403941 [patent_doc_number] => 20190167814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => Treatment And/Or Prevention Of DNA-Triplet Repeat Diseases Or Disorders [patent_app_type] => utility [patent_app_number] => 16/093028 [patent_app_country] => US [patent_app_date] => 2017-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11844 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11836642 [patent_doc_number] => 20170218360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-03 [patent_title] => 'OLIGONUCLEOTIDES FOR MODULATING TARGET RNA ACTIVITY' [patent_app_type] => utility [patent_app_number] => 15/482651 [patent_app_country] => US [patent_app_date] => 2017-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19718 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15482651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12031094 [patent_doc_number] => 20170321192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'Recombinant RNA Viruses and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 15/480800 [patent_app_country] => US [patent_app_date] => 2017-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 49037 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11988005 [patent_doc_number] => 20170292161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-12 [patent_title] => 'METHODS AND COMPOSITIONS FOR DETECTING COLORECTAL NEOPLASIAS USING MICRO RNAs' [patent_app_type] => utility [patent_app_number] => 15/481072 [patent_app_country] => US [patent_app_date] => 2017-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9154 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15481072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11822130 [patent_doc_number] => 20170211066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-27 [patent_title] => 'Methods and Compositions for the Treatment of Prostate Related Disorders using miR-106b' [patent_app_type] => utility [patent_app_number] => 15/480753 [patent_app_country] => US [patent_app_date] => 2017-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 31670 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12002178 [patent_doc_number] => 20170306334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'ANDROGEN RECEPTOR NUCLEIC ACIDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/476293 [patent_app_country] => US [patent_app_date] => 2017-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24192 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11979642 [patent_doc_number] => 20170283795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'PHOSPHATIDYLINOSITOL-3-KINASE NUCLEIC ACIDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/476395 [patent_app_country] => US [patent_app_date] => 2017-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21843 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476395 [rel_patent_id] =>[rel_patent_doc_number] =>)